Insights from Bayer’s $1.5 Billion VC Fund

Discover how Bayer's Leaps Venture Capital arm is transforming the biotech landscape by investing in cutting-edge therapies and technologies. Lucio Iannone, a leading investor at Leaps, shares insights into their unique approach and the future of healthcare.